These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26613641)

  • 1. Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon.
    Felli A; Zeidler P; Jilma B; Opfermann P; Holaubek C; Zimpfer D; Wadowski PP; Steinlechner B
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):96-101. PubMed ID: 26613641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.
    Brinkman HJ; Patiwael S; Tripathi S; Meijers JC
    Thromb Res; 2016 Mar; 139():102-10. PubMed ID: 26916304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
    Dinkelaar J; Patiwael S; Harenberg J; Leyte A; Brinkman HJ
    Clin Chem Lab Med; 2014 Nov; 52(11):1615-23. PubMed ID: 24902009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.
    Perzborn E; Heitmeier S; Laux V; Buchmüller A
    Thromb Res; 2014 Apr; 133(4):671-81. PubMed ID: 24529498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study.
    Song Y; Wang Z; Perlstein I; Wang J; LaCreta F; Frost RJA; Frost C
    J Thromb Haemost; 2017 Nov; 15(11):2125-2137. PubMed ID: 28846831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
    Honickel M; Treutler S; van Ryn J; Tillmann S; Rossaint R; Grottke O
    Thromb Haemost; 2015 Apr; 113(4):728-40. PubMed ID: 25567155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation.
    Dickneite G
    Thromb Res; 2007; 119(5):643-51. PubMed ID: 16842841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo reversal of effects of rivaroxaban evaluated using thromboelastometry and thrombin generation assay.
    Schenk B; Würtinger P; Streif W; Sturm W; Fries D; Bachler M
    Br J Anaesth; 2016 Nov; 117(5):583-591. PubMed ID: 27623677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions.
    Ogawa S; Szlam F; Ohnishi T; Molinaro RJ; Hosokawa K; Tanaka KA
    Thromb Haemost; 2011 Dec; 106(6):1215-23. PubMed ID: 22071880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: a comparison between 3-factor and 4-factor prothrombin complex concentrates.
    Spiezia L; Rossetto V; Campello E; Bulato C; Radu CM; Simioni P
    Blood Coagul Fibrinolysis; 2020 Mar; 31(2):127-131. PubMed ID: 31934885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban.
    Dinkelaar J; Molenaar PJ; Ninivaggi M; de Laat B; Brinkman HJ; Leyte A
    J Thromb Haemost; 2013 Jun; 11(6):1111-8. PubMed ID: 23578206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study.
    Dargaud Y; Desmurs-Clavel H; Marin S; Bordet JC; Poplavsky JL; Negrier C
    J Thromb Haemost; 2008 Jun; 6(6):962-8. PubMed ID: 18373620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative use of prothrombin complex concentrates.
    Colomina MJ; Díez Lobo A; Garutti I; Gómez-Luque A; Llau JV; Pita E
    Minerva Anestesiol; 2012 Mar; 78(3):358-68. PubMed ID: 22357373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass.
    Franklin SW; Szlam F; Fernandez JD; Leong T; Tanaka KA; Guzzetta NA
    Anesth Analg; 2016 Apr; 122(4):935-42. PubMed ID: 26599794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.
    Ghadimi K; Levy JH; Welsby IJ
    Anesth Analg; 2016 May; 122(5):1287-300. PubMed ID: 26983050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model.
    Grottke O; Rossaint R; Henskens Y; van Oerle R; Ten Cate H; Spronk HM
    PLoS One; 2013; 8(5):e64100. PubMed ID: 23696866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation.
    Grottke O; Aisenberg J; Bernstein R; Goldstein P; Huisman MV; Jamieson DG; Levy JH; Pollack CV; Spyropoulos AC; Steiner T; Del Zoppo GJ; Eikelboom J
    Crit Care; 2016 Apr; 20(1):115. PubMed ID: 27125504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced effects of prothrombin complex concentrates in thromboelastometry.
    Scharbert G; Thaler U; Weilnböck C; Wetzel L; Kozek-Langenecker S
    Wien Klin Wochenschr; 2012 May; 124(9-10):320-5. PubMed ID: 22576961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of vitamin K in anticoagulation reversal for hip fracture surgery--a prospective observational study.
    Buecking B; Eschbach D; Bliemel C; Oberkircher L; Struewer J; Ruchholtz S; Sachs UJ
    Thromb Res; 2014 Jan; 133(1):42-7. PubMed ID: 24196230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence?
    Dickneite G; Hoffman M
    Thromb Haemost; 2014 Feb; 111(2):189-98. PubMed ID: 24136202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.